Together with adopting a healthy lifestyle, Medicines are important pillar in
keeping healthy or getting our health back if we may have been ill. However, we
often know very little about the medicines we use. This section is a guide to the
numerous medicines that are registered in Kenya.
We appreciate your feedback! [Last updated Dec:2011]
Displaying 9651-9660 of 12466 results.
Product Name | Dosage Form | Active Ingredients | Manufacturer Name | Class | |
---|---|---|---|---|---|
SII POLIVALENT ANTI SNAKE VENOM SERUM INJECTION | VACCINE | Each 1ml of Serum neutralizes: Standard Black Mamba (Dendroaspis Polylepis) Venom 0.45 mg; Standard Gaboon Viper (Bitis Gabonica Rhinoceros) Venom 0.60 mg; Standard Russell's Viper (Viper russelli) Venom 0.60 mg; Standard Saw-scaled Viper (Echis Carinatus | SERUM INSTITUTE INDIA LTD; INDIA | IMMUNOLOGICALS (VACCINES) | Report Effects |
ABHAYRAB VACCINE (0.5ML) | VACCINE | Inactivated Rabies antigen not less than 2.5 IU/mL | HUMAN BIOLOGICALS INSTITUTE; HUNGARY | IMMUNOLOGICALS (VACCINES) | Report Effects |
ASNA ANTIVENOM INJECTION | INJECTION | Each mL neutralises not less than the following quantities of standard venoms expressed as number of times the LD50 dose: Bitis gabonica 25; Bitis arietans 25; Bitis nasicornis 20; Dendroaspis jamesonii 25; Dendroaspis polylepsis 25; Dendroaspis angustice | BHARAT SERUM AND VACCINES INSTITUTE; INDIA | IMMUNOLOGICALS (VACCINES) | Report Effects |
DPT & HEPATITIS B VACCINE | VACCINE | Active Ingredients per 0.5 mL: Diphtheria Toxoid ? 30 IU; Tetanus Toxoid ? 40 IU; Bordetella Purtussis (whole cell) ? 4 PU; HBsAg (rDNA) ? 10 IU; A1+++ ? 1.25 mg | SERUM INSTITUTE INDIA LTD; INDIA | IMMUNOLOGICALS (VACCINES) | Report Effects |
ROTATEQ ORAL SOLUTION | SOLUTION | G1 Reassortant 3.01 x 106 IU; G2 Reassortant 4.39 x 106 IU; G3 Reassortant 5.98 x 106 IU; G4 Reassortant 3.51 x 106 IU; P1 Reassortant 4.13 x 106 IU | MERCK SHARP & DOHME INTERPHARMA; USA | IMMUNOLOGICALS (VACCINES) | Report Effects |
PREVENAR VACCINE | VACCINE | ACTIVE INGREDIENTS PER 0.5 ML: 2 MCG SACCHARIDE FOR SEROTYPES 4, 9V, 18C, 19F AND 23F; 4MCG OF SEROTYPE 6B PER DOSE (16 MCG TOTAL SACCHARIDE); CONJUGATED TO CRM197 CARRIER PROTEIN | WYETH SA; SOUTH AFRICA | IMMUNOLOGICALS (VACCINES) | Report Effects |
EQUIRAB VACCINE | VACCINE | EQUINE ANT RABIES IMMUNOGLOBULIN FRAGMENTS NOT LESS THAN 300 IU | BHARAT BIOTECH INTERNATIONAL LTD; INDIA | IMMUNOLOGICALS (VACCINES) | Report Effects |
CERVARIX VACCINE | VACCINE | HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN 20 MG; HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN 20 MG; 3-O-DEACYL-4-MONOPHOSPHORYL LIPID A 50 MG | GLAXOSMITHKLINE | IMMUNOLOGICALS (VACCINES) | Report Effects |
VINOBULIN INJECTION 100MCG/500 IU | INJECTION | RHO (D0 IMMUNE GLOBULIN 100MCG/500 IU) | BHARAT BIOTECH INTERNATIONAL LTD; INDIA | IMMUNOLOGICALS (VACCINES) | Report Effects |
DULTAVAX VACCINE | VACCINE | PURIFIED DIPHTHERIA TOXOID 2 IU; PURIFIED TETANUS TOXOID 20 IU; ENHANCED INACTIVATED POLIOMYLETUS VIRUS (E-IPU) TYPE I - 40D UNITS ; TYPE II - 8D UNITS; TYPE III - 32D UNITS PER 0.5 ML | SANOFI PASTEUR | IMMUNOLOGICALS (VACCINES) | Report Effects |